Many with peripheral neuropathy use medications like Gabapentin, Lyrica, or Cymbalta for relief, but these only mask symptoms instead of treating the cause. While they may temporarily reduce pain ...

Peripheral neuropathy is a troubling side effect of certain chemotherapy drugs, known as taxanes, that are commonly used to ...

Clearance of the New Drug Application for ART25.12 allows Artelo to begin a Phase I study for the drug in chemotherapy-induced peripheral neuropathy. The FDA has granted clearance to Artelo ...

A polymer-based device cleared by the FDA offers physicians a new way for repairing peripheral nerve injuries.

Human dorsal root ganglia in a case of diabetic peripheral neuropathy show formation of Nageotte nodules (circled in pink), which appear to be a strong indicator of nerve cell death. A phenomenon ...

The global peripheral neuropathy treatment market is projected to achieve significant growth, with an increase of USD 481.6 million Key drivers include increased prevalence, new drug approvals ...

A Phase 2 test that enrolled more than 400 participants with diabetic peripheral neuropathy is expected to be complete this July, according to an investor presentation that accompanied Lilly’s ...

Lucia Notterpek, Ph.D., professor and senior associate dean for research at the University of Nevada, Reno School of Medicine (UNR Med), has been awarded an Innovation Grants to Nurture Initial ...

Key drivers include increased prevalence, new drug approvals, and rising awareness. The report offers comprehensive analysis, segmentation by type, therapy, and region, and a vendor landscape, aiding ...